The primary investment objective of the scheme is to seek to generate consistent returns bypredominantly investing in equity and equity related securities of pharmaceutical and healthcarecompanies.
Investors understand that their principal will be at very high risk
Category
Sector Funds
Launch Date
30-Nov-18
Scheme Benchmark
S&P BSE HEALTH CARE - TRI
AUM ( in Cr.)
2,352.32
portfolio price to book value
6.64
investing style?
Large Growth
fund manager?
Chirag Dagli,Jay Kothari
inception date (regular plan)
expense ratio (regular plan) %
1.98